Bristol sees annual $1.5B in cost savings by end of 2025

Bristol Myers Squibb (NYSE:BMY) said that ongoing initiatives to cut costs will lead to the realization of $1.5B in annual cost savings by the end of the year.

Speaking at the J.P. Morgan Healthcare Conference in San Francisco on Monday, CEO Christopher